The UK electronic health record market size was valued at $736 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $862 Mn in 2030. This growth can be attributed to Technological advancements in healthcare offering a promising future for enhancing healthcare delivery through electronic health records. The market is segmented by product type, application type, and end user. Some of the major players are Cerner Healthcare, InPS, System C & Graphnet Health, TPP, and others.
The current demographics in UK make it an ideal market as the demand for anti-aging and overall skincare products is high thereby resulting in the growth of the UK anti-aging market during the forecast period. The market is segmented by product type, service type, route of administration and device type.
The UK patient support programs is expected to witness growth as the demand for more personalized medicine and care is increasing in the UK. Patients and Healthcare Services by Biogen and Together Enbrel Patient Support Program by Pfizer are some of the major pharma-sponsored PSPs in UK.
This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK ePharmacy Market, offering unmatched value, accuracy and expert insights.
The UK Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-2030. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. The market is segmented by type and by gender. Some key players in this market include Renishaw, LivaNova, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
A major chunk of the population in UK suffers from skin diseases making it a desirable market for pharmaceutical companies. Eczema, psoriasis, and melanoma are some of the major dermatological disorders prevalent in the UK. Over the counter drugs hold a major share of the UK dermatology market.
The rising prevalence of mobility-impairing diseases and the increasing geriatric population requiring Long Term Care (LTC) in UK are the major market drivers for the growth of UK mobility aids market. Human Care and Drive Devilbiss Healthcare are some of the key players in the market.
An aging population and the increased prevalence of cardiovascular, neuromuscular, and musculoskeletal diseases in UK are most likely to propel the growth of the UK hand therapy market. Complex regional pain syndrome and fractures are major conditions that require hand therapy in UK.
UK physiotherapy market is at around $1.38 Bn in 2022 and is expected to grow to $1.87 Bn in 2030 with a CAGR of 3.85% for the year 2022-2030. The increasing geriatric population and high prevalence of musculoskeletal disorders are the major market drivers of UK physiotherapy market. The UK physiotherapy market is segmented by treatment and conditions.